Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.businesswire.com/news/home/20210412005256/en/Amphivena-Presents-Translational-Data-Highlighting-the-Cytokine-Profile-for-its-Lead-Clinical-Candidate-AMV564-at-the-AACR-2021-Virtual-Annual-Meeting
https://www.biospace.com/article/releases/amphivena-therapeutics-announces-first-patient-dosed-in-the-phase-1-dose-expansion-of-amv564/
https://www.prnewswire.com/news-releases/amphivena-presents-clinical-update-and-translational-data-of-amv564-in-solid-tumor-patients-at-the-2020-society-for-immunotherapy-of-cancer-sitc-annual-meeting-301168849.html
https://www.prnewswire.com/news-releases/amphivena-presents-translational-data-for-its-lead-clinical-candidate-amv564-at-the-aacr-2020-virtual-annual-meeting-ii-301081527.html
https://www.prnewswire.com/news-releases/amphivena-therapeutics-to-present-at-the-jefferies-virtual-healthcare-conference-301067569.html
https://www.prnewswire.com/news-releases/amphivena-presents-data-from-first-in-human-study-of-amv564-in-solid-tumor-patients-at-the-asco-virtual-annual-meeting-2020-301067574.html
https://www.prnewswire.com/news-releases/amphista-therapeutics-raises-7-5m-series-a-round-to-advance-targeted-protein-degradation-assets-in-cancer-301035867.html
https://www.prnewswire.com/news-releases/amphista-therapeutics-raises-7-5m-series-a-round-to-advance-targeted-protein-degradation-assets-in-cancer-301035867.html